DDX3X and breast carcinoma: Furthermore, the fact that DDX3X possesses a proproliferative function in breast cancer cells but not in nontumourigenic breast epithelial cells 26, highlights this RNA helicase as a potential therapeutic target in the fight against breast cancer.